11
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Intermittent Androgen Suppression: Too Good to be True?

Pages 45-49 | Published online: 09 Jul 2009
 

Abstract

The progression of metastatic prostate cancers to an androgen-independent state removes the possibility of further androgen therapy. In response to this, new treatments that do not cause the loss of androgen sensitivity have been sought. Intermittent androgen suppression therapy, an adaptation of the previously used androgen ablation techniques, has shown great promise, comparing favourably with continuous androgen deprivation in pilot studies. It may, therefore, prove to be an excellent treatment, both individually and in combination, although further studies are required.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.